Agency Forms Undergoing Paperwork Reduction Act Review, 19307-19308 [2023-06736]
Download as PDF
<![CDATA[
19307
Federal Register / Vol. 88, No. 62 / Friday, March 31, 2023 / Notices
Please note: Submit all comments
through the Federal eRulemaking portal
(www.regulations.gov) or by U.S. mail to
the address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS
H21–8, Atlanta, Georgia 30329;
Telephone: 404–639–7570; Email: omb@
cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
which is an urgent national and global
health threat. Additionally,
inappropriate antibiotic prescribing
contributes to avoidable adverse drug
events that cause substantial harms to
patients. Most antibiotic prescribing
originates in traditional outpatient
settings such as physician offices and
emergency departments, and at least
30% of these prescriptions are
completely unnecessary.
Over the past decade there has been
rapid growth in non-traditional
outpatient settings including Urgent
Care clinics. Recent evidence shows that
when compared to traditional office
settings, inappropriate antibiotic
prescribing is substantially higher in
Urgent Care clinics making this an
important priority for antibiotic
stewardship. The design, development,
and evaluation of durable stewardship
interventions addressing the unique
setting of Urgent Care clinics is an
important area of unmet need. This data
collection will assess knowledge,
attitudes, and practices related to
antibiotic prescribing among clinicians
after implementation of a year-long
Urgent Care stewardship initiative.
CDC requests OMB approval for an
estimated 62 annualized burden hours.
There is no cost to respondents other
than their time to participate.
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected;
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses; and
5. Assess information collection costs.
Proposed Project
Validated Interview and Survey of
Outpatient Providers on Antibiotic
Stewardship Interventions (OMB
Control No. 0920–1308)—
Reinstatement—National Center for
Emerging Zoonotic and Infectious
Disease (NCEZID), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
Inappropriate antibiotic prescribing is
a major driver of antibiotic resistance
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Total burden
(in hours)
Form name
Urgent Care Clinician ........................
Urgent Care Clinician ........................
Interview Guide ................................
Survey ..............................................
20
125
1
1
1
20/60
20
42
Total ...........................................
...........................................................
........................
........................
........................
62
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2023–06734 Filed 3–30–23; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
BILLING CODE 4163–18–P
[30Day–23–1215]
Agency Forms Undergoing Paperwork
Reduction Act Review
ddrumheller on DSK120RN23PROD with NOTICES1
Average
burden per
response
(in hours)
Number of
responses per
respondent
Type of respondents
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled ‘‘Awardee Lead
Profile Assessment (ALPA)’’ to the
Office of Management and Budget
(OMB) for review and approval. CDC
VerDate Sep<11>2014
17:54 Mar 30, 2023
Jkt 259001
PO 00000
Frm 00070
Fmt 4703
Sfmt 4703
previously published a ‘‘Proposed Data
Collection Submitted for Public
Comment and Recommendations’’
notice on December 20, 2022, to obtain
comments from the public and affected
agencies. CDC did not receive comments
related to the previous notice. This
notice serves to allow an additional 30
days for public and affected agency
comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
E:\FR\FM\31MRN1.SGM
31MRN1
19308
Federal Register / Vol. 88, No. 62 / Friday, March 31, 2023 / Notices
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570.
Comments and recommendations for the
proposed information collection should
be sent within 30 days of publication of
this notice to www.reginfo.gov/public/
do/PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function. Direct written
comments and/or suggestions regarding
the items contained in this notice to the
Attention: CDC Desk Officer, Office of
Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by
fax to (202) 395–5806. Provide written
comments within 30 days of notice
publication.
Proposed Project
Awardee Lead Profile Assessment
(ALPA) (OMB Control No. 0920–1215,
Exp. 03/31/2024)—Revision—National
Center for Environmental Health
(NCEH), Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
The Centers for Disease Control and
Prevention (CDC) is requesting
Paperwork Reduction Act (PRA)
clearance for a three-year revised
Information Collection Request (ICR)
titled ‘‘Awardee Lead Profile
Assessment (ALPA)’’ (OMB Control No.
0920–1215; Exp. 03/31/2024). The goal
of this ICR is to build on the CDC’s
existing childhood lead poisoning
prevention program. CDC requires that
ongoing and new CDC Childhood Lead
Poisoning Prevention Programs
(CLPPPs), including the FY21
‘‘Childhood Lead Poisoning Prevention
and Surveillance of Blood Lead Levels
in Children’’ (CDC–RFA–EH21–2102),
complete the ALPA annually. This
annual information collection will be
used to identify jurisdictional legal
frameworks governing CDC-funded
CLPPPs in the United States and
strategies for implementing childhood
lead poisoning prevention activities.
CDC can use this information to inform
guidance, resource development, and
technical assistance activities in support
of the ultimate goal, which is
eliminating lead exposure in children.
The dissemination of these ALPA
results will ensure that both funded and
non-funded jurisdictions are able to: (1)
identify policies and other factors that
support or hinder childhood lead
poisoning prevention efforts; (2)
understand what strategies are being
used by funded public health agencies
to implement childhood lead poisoning
prevention activities; and (3) use this
knowledge to develop and apply similar
strategies to support the national agenda
to eliminate childhood lead poisoning.
This program management information
collection has been revised in several
ways, including the addition of new
answer options and questions to
understand usage of the updated blood
lead reference value (BLRV).
CDC will use one data collection
mode, a web survey. A change in the
mode of collection will not affect the
total time burden requested as the time
per response is the same for either
mode, and the time to take the survey
has remained consistent from 2021
estimates (47 minutes per response)
despite revisions to the survey. This
time estimate per response is based on
pilot tests of the revised survey among
eight respondents, and includes the
time needed to review the ALPA
Training Manual.
In total, the annual number of
respondents remains unchanged at 75,
and the annual time burden requested
remains at 59 hours. There are no costs
to respondents other than their time.
The respondents are participating in
this survey as a program requirement.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Type of respondents
Form name
State or Local Governments (or their bona fide fiscal agents)
ALPA Web Survey .................
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2023–06736 Filed 3–30–23; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
BILLING CODE 4163–18–P
ddrumheller on DSK120RN23PROD with NOTICES1
[60Day–23–23DT; Docket No. CDC–2023–
0022]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
VerDate Sep<11>2014
17:54 Mar 30, 2023
Jkt 259001
PO 00000
Frm 00071
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
75
1
Average
burden per
response
(in hours)
47/60
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
Government information, invites the
general public and other Federal
agencies the opportunity to comment on
a proposed information collection, as
required by the Paperwork Reduction
Act of 1995. This notice invites
comment on a proposed information
collection project titled Reporting of the
Essentials for Childhood (EfC):
Preventing Adverse Childhood
Experiences through Data to Action
Program. This data collection will help
to ensure that associated programs are
SUMMARY:
E:\FR\FM\31MRN1.SGM
31MRN1
]]>Agencies
[Federal Register Volume 88, Number 62 (Friday, March 31, 2023)]
[Notices]
[Pages 19307-19308]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-06736]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-23-1215]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled ``Awardee Lead Profile Assessment (ALPA)'' to
the Office of Management and Budget (OMB) for review and approval. CDC
previously published a ``Proposed Data Collection Submitted for Public
Comment and Recommendations'' notice on December 20, 2022, to obtain
comments from the public and affected agencies. CDC did not receive
comments related to the previous notice. This notice serves to allow an
additional 30 days for public and affected agency comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the
[[Page 19308]]
functions of the agency, including whether the information will have
practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570. Comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct
written comments and/or suggestions regarding the items contained in
this notice to the Attention: CDC Desk Officer, Office of Management
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202)
395-5806. Provide written comments within 30 days of notice
publication.
Proposed Project
Awardee Lead Profile Assessment (ALPA) (OMB Control No. 0920-1215,
Exp. 03/31/2024)--Revision--National Center for Environmental Health
(NCEH), Centers for Disease Control and Prevention (CDC).
Background and Brief Description
The Centers for Disease Control and Prevention (CDC) is requesting
Paperwork Reduction Act (PRA) clearance for a three-year revised
Information Collection Request (ICR) titled ``Awardee Lead Profile
Assessment (ALPA)'' (OMB Control No. 0920-1215; Exp. 03/31/2024). The
goal of this ICR is to build on the CDC's existing childhood lead
poisoning prevention program. CDC requires that ongoing and new CDC
Childhood Lead Poisoning Prevention Programs (CLPPPs), including the
FY21 ``Childhood Lead Poisoning Prevention and Surveillance of Blood
Lead Levels in Children'' (CDC-RFA-EH21-2102), complete the ALPA
annually. This annual information collection will be used to identify
jurisdictional legal frameworks governing CDC-funded CLPPPs in the
United States and strategies for implementing childhood lead poisoning
prevention activities. CDC can use this information to inform guidance,
resource development, and technical assistance activities in support of
the ultimate goal, which is eliminating lead exposure in children. The
dissemination of these ALPA results will ensure that both funded and
non-funded jurisdictions are able to: (1) identify policies and other
factors that support or hinder childhood lead poisoning prevention
efforts; (2) understand what strategies are being used by funded public
health agencies to implement childhood lead poisoning prevention
activities; and (3) use this knowledge to develop and apply similar
strategies to support the national agenda to eliminate childhood lead
poisoning. This program management information collection has been
revised in several ways, including the addition of new answer options
and questions to understand usage of the updated blood lead reference
value (BLRV).
CDC will use one data collection mode, a web survey. A change in
the mode of collection will not affect the total time burden requested
as the time per response is the same for either mode, and the time to
take the survey has remained consistent from 2021 estimates (47 minutes
per response) despite revisions to the survey. This time estimate per
response is based on pilot tests of the revised survey among eight
respondents, and includes the time needed to review the ALPA Training
Manual.
In total, the annual number of respondents remains unchanged at 75,
and the annual time burden requested remains at 59 hours. There are no
costs to respondents other than their time. The respondents are
participating in this survey as a program requirement.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per
Type of respondents Form name respondents responses per response (in
respondent hours)
----------------------------------------------------------------------------------------------------------------
State or Local Governments (or their ALPA Web Survey......... 75 1 47/60
bona fide fiscal agents).
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2023-06736 Filed 3-30-23; 8:45 am]
BILLING CODE 4163-18-P
